RPG Life Sciences Ltd
₹1881
(-0.32%)
Sat, 11 Apr 2026, 01:21 pm
RPG Life Sciences Debt to Equity Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 5.03 | 11.19 | 9.86 | 125.29 | 23.22 | 1.86 | 275.67 | 31.64 | 54.59 | 47.06 | 37.90 | 9.72 | 16.01 | 17.98 | 17.02 | 28.87 | 20.56 |
| Price to book ratio | 0 | 0 | 0 | 0.60 | 1.71 | 1.68 | 1.43 | 1.34 | 0.79 | 2.19 | 2.75 | 5.06 | 4.09 | 2.55 | 1.60 | 2.96 | 3.62 | 3.74 | 6.75 | 7.10 |
| Price to sales ratio | 0 | 0 | 0 | 0.24 | 0.76 | 0.68 | 0.56 | 0.47 | 0.44 | 1.17 | 1.46 | 2.58 | 1.87 | 1.26 | 0.76 | 1.67 | 2.11 | 2.26 | 4.37 | 5.80 |
| Price to cash flow ratio | 0 | 0 | 0 | 1.65 | 9.64 | 14.74 | 10.97 | 20.30 | 0 | 0 | 12.11 | 143.06 | 58 | 9.78 | 5.77 | 11.03 | 14.09 | 12.34 | 26.55 | 46.82 |
| Enterprise value | 0 | 0 | 0 | 897.36M | 1.69B | 1.78B | 1.59B | 1.65B | 1.13B | 3.06B | 3.9B | 7.87B | 6.86B | 4.45B | 2.93B | 6.01B | 8.56B | 10.35B | 24.04B | 35.01B |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 3.72 | 5.84 | 5.90 | 10.88 | 15.43 | 18.90 | 61.39 | 25.75 | 32.78 | 20.98 | 14.96 | 5.33 | 9.09 | 9.94 | 10.06 | 18.92 | 21.87 |
| Debt to equity ratio | 1.46 | 1.17 | 0.02 | 1.03 | 0.76 | 0.71 | 0.73 | 0.83 | 0.12 | 0.27 | 0.17 | 0.30 | 0.35 | 0.23 | 0.07 | 0.01 | 0 | 0 | 0 | 0 |
| Return on equity % | 62.91 | 11.87 | -44.05 | 11.22 | 18.09 | 18.26 | 1.14 | 5.87 | 52.87 | 0.80 | 6.49 | 8.62 | 8.71 | 6.86 | 17.21 | 20.36 | 21.80 | 24.01 | 25.69 | 40.48 |
RPG Life Sciences Ltd Debt to Equity Ratio
The RPG Life Sciences Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate RPG Life Sciences Ltd's valuation, profitability, and overall financial performance. Tracking the RPG Life Sciences Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
RPG Life Sciences Ltd (NSE: RPGLIFE, BSE: 532983) is currently trading at ₹1881, with a market capitalization of ₹31.08B. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the RPG Life Sciences Ltd Debt to Equity Ratio is essential for fundamental analysis.
RPG Life Sciences Ltd Debt to Equity Ratio Current Value
The current RPG Life Sciences Ltd Debt to Equity Ratio stands at 0.
The RPG Life Sciences Ltd Debt to Equity Ratio remains stable, indicating consistent financial performance.
RPG Life Sciences Ltd Debt to Equity Ratio Historical Trend
The RPG Life Sciences Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 0
- 2020: 0.01
The decline in RPG Life Sciences Ltd Debt to Equity Ratio indicates improving financial efficiency or better earnings growth.
What RPG Life Sciences Ltd Debt to Equity Ratio Indicates for Investors
The RPG Life Sciences Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
RPG Life Sciences Ltd Debt to Equity Ratio Analysis Summary
The RPG Life Sciences Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking RPG Life Sciences Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of RPG Life Sciences Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800